These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 9711798)
1. Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. Chinsangaram J; Mason PW; Grubman MJ Vaccine; 1998 Oct; 16(16):1516-22. PubMed ID: 9711798 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Mason PW; Piccone ME; Mckenna TS; Chinsangaram J; Grubman MJ Virology; 1997 Jan; 227(1):96-102. PubMed ID: 9007062 [TBL] [Abstract][Full Text] [Related]
3. Construction and evaluation of an attenuated vaccine for foot-and-mouth disease: difficulty adapting the leader proteinase-deleted strategy to the serotype O1 virus. Almeida MR; Rieder E; Chinsangaram J; Ward G; Beard C; Grubman MJ; Mason PW Virus Res; 1998 May; 55(1):49-60. PubMed ID: 9712511 [TBL] [Abstract][Full Text] [Related]
4. Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines. Morgan DO; Moore DM Am J Vet Res; 1990 Jan; 51(1):40-5. PubMed ID: 2154148 [TBL] [Abstract][Full Text] [Related]
5. Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. Chinsangaram J; Piccone ME; Grubman MJ J Virol; 1999 Dec; 73(12):9891-8. PubMed ID: 10559301 [TBL] [Abstract][Full Text] [Related]
6. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus. Li X; Liu R; Tang H; Jin M; Chen H; Qian P Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351 [TBL] [Abstract][Full Text] [Related]
7. Prospects, including time-frames, for improved foot and mouth disease vaccines. Grubman MJ; Mason PW Rev Sci Tech; 2002 Dec; 21(3):589-600. PubMed ID: 12523699 [TBL] [Abstract][Full Text] [Related]
8. Synonymous Deoptimization of Foot-and-Mouth Disease Virus Causes Attenuation In Vivo while Inducing a Strong Neutralizing Antibody Response. Diaz-San Segundo F; Medina GN; Ramirez-Medina E; Velazquez-Salinas L; Koster M; Grubman MJ; de los Santos T J Virol; 2016 Feb; 90(3):1298-310. PubMed ID: 26581977 [TBL] [Abstract][Full Text] [Related]
10. Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs. Mayr GA; O'Donnell V; Chinsangaram J; Mason PW; Grubman MJ Vaccine; 2001 Feb; 19(15-16):2152-62. PubMed ID: 11228388 [TBL] [Abstract][Full Text] [Related]
11. The immunopotentiator CVC1302 enhances immune efficacy and protective ability of foot-and-mouth disease virus vaccine in pigs. Chen J; Yu X; Zheng Q; Hou L; Du L; Zhang Y; Qiao X; Hou J; Huang K Vaccine; 2018 Dec; 36(52):7929-7935. PubMed ID: 30470640 [TBL] [Abstract][Full Text] [Related]
12. Layered double hydroxide nanoparticles as an adjuvant for inactivated foot-and-mouth disease vaccine in pigs. Wu P; Zhang Y; Yin X; He Y; Zhang Q; Chen C BMC Vet Res; 2020 Dec; 16(1):474. PubMed ID: 33276787 [TBL] [Abstract][Full Text] [Related]
13. Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle. Dar P; Kalaivanan R; Sied N; Mamo B; Kishore S; Suryanarayana VV; Kondabattula G Vaccine; 2013 Jul; 31(33):3327-32. PubMed ID: 23735678 [TBL] [Abstract][Full Text] [Related]
14. BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs. Kim A; Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM J Virol; 2022 Jun; 96(12):e0052822. PubMed ID: 35604219 [TBL] [Abstract][Full Text] [Related]
15. A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals. Uddowla S; Hollister J; Pacheco JM; Rodriguez LL; Rieder E J Virol; 2012 Nov; 86(21):11675-85. PubMed ID: 22915802 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of novel inactivated vaccines for the SAT 1, SAT 2 and SAT 3 serotypes of foot-and-mouth disease in pigs. Jo HE; You SH; Choi JH; Ko MK; Shin SH; Song J; Jo H; Lee MJ; Kim SM; Kim B; Park JH Virol J; 2019 Dec; 16(1):156. PubMed ID: 31842907 [TBL] [Abstract][Full Text] [Related]
17. Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine. Beard C; Ward G; Rieder E; Chinsangaram J; Grubman MJ; Mason PW J Biotechnol; 1999 Aug; 73(2-3):243-9. PubMed ID: 10486933 [TBL] [Abstract][Full Text] [Related]
18. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Moraes MP; Chinsangaram J; Brum MC; Grubman MJ Vaccine; 2003 Dec; 22(2):268-79. PubMed ID: 14615155 [TBL] [Abstract][Full Text] [Related]
19. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals. Grubman MJ Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996 [TBL] [Abstract][Full Text] [Related]